Niflumic acid, 99+%
Niflumic acid, 99+%
Niflumic acid, 99+%
Thermo Scientific Chemicals

Niflumic acid, 99+%

CAS: 4394-00-7 | C13H9F3N2O2 | 282.22 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
50 g
5 g
10 g
Catalog number ALFJ60489.18
View Price:Sign in to see your account pricing. Need an account? Register with us today.
Quantity:
50 g
Request bulk or custom format
Specifications
Chemical Name or MaterialNiflumic acid
CAS4394-00-7
Health Hazard 1H302+H312+H332-H315-H319-H335
Health Hazard 2GHS H Statement
H301-H312-H332-H315-H319-H335
Toxic if swallowed.
Harmful in contact with skin.
Harmful if inhaled.
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Health Hazard 3P261-P264b-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P312-P330-P332+P313-P362-P501c
View more
It is used as a selective Cox-2 inhibitor and GPR35 activator. Also activates human TRPA1 inducibly expressed in HEK293 cells; displays agonist activity at GPR35.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
It is used as a selective Cox-2 inhibitor and GPR35 activator. Also activates human TRPA1 inducibly expressed in HEK293 cells; displays agonist activity at GPR35.

Solubility
Soluble in ethanol (∼50 mg/ml), acetone (50 mg/ml, Clear to Slightly Hazy, Yellow), methanol (∼50 mg/ml), DMSO (56 mg/ml at 25°C), and acetonitrile (∼50 mg/ml).

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Light sensitive. Hygroscopic. Keep away fom strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Ottolia .; Toro. Potentiation of large conductance KCa channels by niflumic, flufenamic and mefenamic acids. Biophys.J. 1994, 67 ,(6), 2272-9.
  2. Famaey. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm.Res. 1997, 46 ,(11), 437-46.